Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
4,030.00
+85.00 (2.15%)
At close: Aug 24, 2026
Jin Yang Pharmaceutical Revenue
Jin Yang Pharmaceutical had revenue of 32.65B KRW in the quarter ending June 30, 2026, with 8.16% growth. This brings the company's revenue in the last twelve months to 124.61B, up 4.12% year-over-year. In the year 2025, Jin Yang Pharmaceutical had annual revenue of 120.69B with 6.49% growth.
Revenue (ttm)
124.61B
Revenue Growth
+4.12%
P/S Ratio
0.41
Revenue / Employee
566.41M
Employees
220
Market Cap
50.93B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 120.69B | 7.35B | 6.49% |
| Dec 31, 2024 | 113.33B | 19.62B | 20.94% |
| Dec 31, 2023 | 93.71B | 17.44B | 22.87% |
| Dec 31, 2022 | 76.26B | 13.43B | 21.36% |
| Dec 31, 2021 | 62.84B | 13.31B | 26.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| RP Bio | 141.42B |
| Sinsin Pharmaceutical | 118.65B |
| Hwail Pharmaceutical | 107.87B |
| GeneBioTech Co. ,Ltd | 89.44B |
| Sinil Pharmaceutical | 82.18B |
| Samik Pharmaceutical Company LTD. | 61.48B |
| GL Pharm Tech | 38.21B |
| Optipharm.CO.,LTD | 22.79B |